<?xml version="1.0" encoding="UTF-8"?>
<p>The study will enrol a minimum of 140 adult patients with definite or probable CIDP according to EFNS/PNS criteria
 <xref rid="jns12267-bib-0001" ref-type="ref">1</xref> from approximately 45 study sites worldwide. The enrolment period is expected to last for about 20â€‰months. Eligible patients will be those who have active disease (defined below) and are dependent on IVIg or corticosteroids.
</p>
